CapForce Inc (CapForce) is a precision medicine company that uses molecular diagnostics and informatics to prevent infectious disease. OpGen’s product portfolio includes AREScloud, ARESdb, Unyvero LRT Panels, Unyvero Urinary Tract Infection (UTI) Panel, Unyvero System, SARS-CoV-2 test kit, Acuitas molecular diagnostics.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company invested in the development of additional Unyvero panels, including the Unyvero UTI panel and the Unyvero IJI panel. It also invested in the further development of the Unyvero A30 RQ platform and the Ares Genetics bioinformatics solutions, such as ARESdb and ares-genetics cloud. In FY2024, the company incurred research and development (R&D) expenses of US$0.05 million.